|
Market Closed -
Other stock markets
|
After hours 02:29:54 am | |||
| 82.41 EUR | -2.40% |
|
81.85 | -0.68% |
| 12:35am | Sanofi Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:45 AM | |
| 09:50pm | European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading | MT |
Company Valuation: Sanofi
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 98,877 | 1,11,194 | 1,12,665 | 1,12,549 | 1,16,968 | 1,00,277 | 1,00,277 | - |
| Change | - | 12.46% | 1.32% | -0.1% | 3.93% | -14.27% | 0% | - |
| Enterprise Value (EV) 1 | 1,07,666 | 1,21,177 | 1,19,102 | 1,20,342 | 1,25,740 | 1,12,661 | 1,09,864 | 1,07,329 |
| Change | - | 12.55% | -1.71% | 1.04% | 4.49% | -10.4% | -2.48% | -2.31% |
| P/E ratio | 8.01x | 17.8x | 16.7x | 20.8x | 20.4x | 12.3x | 12x | 11x |
| PBR | 1.57x | 1.62x | 1.5x | 1.52x | 1.51x | 1.29x | 1.23x | 1.17x |
| PEG | - | -0.4x | 2.07x | -1.1x | 3.14x | 0.3x | 6.96x | 1.1x |
| Capitalization / Revenue | 2.74x | 2.94x | 2.62x | 2.61x | 2.85x | 2.31x | 2.17x | 2.04x |
| EV / Revenue | 2.99x | 3.21x | 2.77x | 2.79x | 3.06x | 2.59x | 2.37x | 2.18x |
| EV / EBITDA | 9.41x | 9.95x | 8.14x | 8.44x | 9.76x | 8.44x | 7.7x | 7.07x |
| EV / EBIT | 11x | 11.3x | 9.13x | 9.5x | 11.1x | 9.31x | 8.4x | 7.66x |
| EV / FCF | 15.4x | 15x | 14x | 14.2x | 21.1x | 18.8x | 12.3x | 10.5x |
| FCF Yield | 6.48% | 6.68% | 7.12% | 7.04% | 4.74% | 5.31% | 8.14% | 9.52% |
| Dividend per Share 2 | 3.2 | 3.33 | 3.56 | 3.76 | 3.92 | 4.117 | 4.254 | 4.463 |
| Rate of return | 4.07% | 3.76% | 3.96% | 4.19% | 4.18% | 5% | 5.16% | 5.42% |
| EPS 2 | 9.82 | 4.97 | 5.37 | 4.31 | 4.59 | 6.726 | 6.842 | 7.526 |
| Distribution rate | 32.6% | 67% | 66.3% | 87.2% | 85.4% | 61.2% | 62.2% | 59.3% |
| Net sales 1 | 36,041 | 37,761 | 42,997 | 43,070 | 41,081 | 43,458 | 46,275 | 49,179 |
| EBITDA 1 | 11,443 | 12,183 | 14,627 | 14,259 | 12,889 | 13,348 | 14,262 | 15,179 |
| EBIT 1 | 9,762 | 10,714 | 13,040 | 12,670 | 11,343 | 12,097 | 13,074 | 14,013 |
| Net income 1 | 12,314 | 6,223 | 6,720 | 5,400 | 5,744 | 8,259 | 8,455 | 9,262 |
| Net Debt 1 | 8,789 | 9,983 | 6,437 | 7,793 | 8,772 | 12,384 | 9,587 | 7,051 |
| Reference price 2 | 78.70 | 88.58 | 89.84 | 89.76 | 93.74 | 82.41 | 82.41 | 82.41 |
| Nbr of stocks (in thousands) | 12,56,375 | 12,55,293 | 12,54,060 | 12,53,891 | 12,47,793 | 12,16,810 | 12,16,810 | - |
| Announcement Date | 05/02/21 | 04/02/22 | 03/02/23 | 01/02/24 | 30/01/25 | - | - | - |
1EUR in Million2EUR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.56x | 2.65x | 8.63x | 4.88% | 12TCr | ||
| 46.47x | 15.39x | 34.15x | 0.55% | 95TCr | ||
| 19.66x | 5.52x | 15.38x | 2.53% | 49TCr | ||
| 74.58x | 7.29x | 17.31x | 2.97% | 39TCr | ||
| 19.48x | 4.96x | 12.35x | 2.9% | 36TCr | ||
| 28.79x | 5.41x | 16.04x | 1.69% | 30TCr | ||
| 14.2x | 4.62x | 9.95x | 2.93% | 27TCr | ||
| 19.94x | 5.27x | 12.38x | 2.87% | 27TCr | ||
| 16.55x | 5.85x | 12.09x | 3.05% | 26TCr | ||
| 25.78x | 6.06x | 10.38x | 2.93% | 18TCr | ||
| Average | 27.80x | 6.30x | 14.86x | 2.73% | 35.99TCr | |
| Weighted average by Cap. | 32.86x | 8.12x | 18.95x | 2.22% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- SAN Stock
- Valuation Sanofi
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















